Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction - National Registry of Myocardial Infarction

被引:105
|
作者
Spencer, FA
Fonarow, GC
Frederick, PD
Wright, RS
Every, N
Goldberg, RJ
Gore, JM
Dong, W
Becker, RC
French, W
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Univ Calif Los Angeles, Cardiomyopathy Ctr, Div Cardiol, Los Angeles, CA USA
[3] Ovat Res Grp, Seattle, WA USA
[4] Mayo Clin, Dept Med, Rochester, MN USA
[5] Univ Washington, Dept Med, Seattle, WA 98195 USA
[6] Genentech Inc, San Francisco, CA 94080 USA
[7] Duke Univ, Dept Med, Durham, NC USA
[8] Harbor UCLA Med Ctr, Dept Med, Los Angeles, CA USA
关键词
D O I
10.1001/archinte.164.19.2162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is increasing interest in the nonlipid-lowering effects of statins and their effect on outcomes in patients with acute coronary syndrome. It has been suggested that withdrawal of statin therapy during an acute coronary syndrome may attenuate any benefits of pretreatment, thereby providing indirect evidence of the importance of their non-lipid-lowering effects. Methods: This observational study compared the demographic and clinical characteristics and hospital outcomes in patients, with non-ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction 4. Comparison groups consisted of patients previously receiving statins who also received statins within 24 hours of hospital admission (n=9001), patients previously using statins in whom therapy was discontinued (n=4870), and patients who did not receive statins at any time before or during hospitalization (n=54635). Results: Of 13 871 patients receiving statins before hospital admission, 35.1% had treatment withdrawn during the first 24 hours of hospitalization. These patients had increased hospital morbidity and mortality rates relative to patients in whom therapy was continued, with higher rates of heart failure, ventricular arrhythmias, shock, and death. In multivariate analyses, these patients were at statistically significant increased risk of hose pital death compared with those continuing statin therapy and at similar risk compared with those not receiving statins before or during hospitalization. Conclusions: withdrawal of statin therapy in the first 24 hours of hospitalization for non-ST-segment elevation myocardial infarction is associated with worse hospital outcomes. In the absence of data from randomized clinical trials, our findings suggest that statin therapy should be continued during hospitalization for myocardial infarction unless strongly contraindicated.
引用
收藏
页码:2162 / 2168
页数:7
相关论文
共 50 条
  • [1] Application of the thrombolysis in myocardial infarction risk index in non-ST-segment elevation myocardial infarction - Evaluation of patients in the National Registry of Myocardial Infarction
    Wiviott, SD
    Morrow, DA
    Frederick, PD
    Antman, EM
    Braunwald, E
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (08) : 1553 - 1558
  • [2] Does the "Obesity paradox" extend to patients with non-ST-segment elevation myocardial infarction? Insight from the National Registry for Myocardial Infarction 4
    Wright, RS
    Murphy, JG
    Frederick, P
    Jaffe, AS
    French, WJ
    [J]. CIRCULATION, 2004, 110 (17) : 660 - 660
  • [3] Impact of QRS Duration on Non-ST-Segment Elevation Myocardial Infarction (from a National Registry)
    Moledina, Saadiq M.
    Mannan, Fahmida
    Weight, Nicholas
    Alisiddiq, Zaheer
    Elbadawi, Ayman
    Elgendy, Islam Y.
    Fischman, David L.
    Mamas, Mamas A.
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2022, 183 : 1 - 7
  • [4] Management of non-ST-Segment elevation myocardial infarction
    Van Horn, Stephen E.
    Maniu, Calin V.
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2007, 91 (04) : 683 - +
  • [5] THE PLATELET PHENOTYPE IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IS DIFFERENT FROM NON-ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Cameron, Scott J.
    Schmidt, Rachel A.
    Simlote, Preya
    Ling, Fred
    Fernandez, Genaro
    Gervase, Joe
    Adler, David
    Morrell, Craig
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (04) : 785 - 786
  • [6] The platelet phenotype in patients with ST-segment elevation myocardial infarction is different from non-ST-segment elevation myocardial infarction
    Schmidt, Rachel A.
    Morrell, Craig N.
    Ling, Frederick S.
    Simlote, Preya
    Fernandez, Genaro
    Rich, David Q.
    Adler, David
    Gervase, Joe
    Cameron, Scott J.
    [J]. TRANSLATIONAL RESEARCH, 2018, 195 : 1 - 12
  • [7] Myocardial infarction: when ST-segment elevation versus non-ST-segment elevation myocardial infarction paradigm fails
    Terlecki, Michal
    Rajzer, Marek
    Czarnecka, Danuta
    [J]. KARDIOLOGIA POLSKA, 2019, 77 (03) : 396 - 396
  • [8] The "smoker paradox" in older patients with non-ST-segment elevation myocardial infarction in the CRUSADE Registry
    Lin, Gen-Min
    Li, Yi-Hwei
    [J]. AMERICAN HEART JOURNAL, 2014, 167 (06)
  • [9] Prognosis of patients with cardiogenic shock following acute myocardial infarction: The difference between ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction
    Tsai, Ming-Lung
    Hsieh, Ming-Jer
    Chen, Chun-Chi
    Wu, Victor Chien-Chia
    Lan, Wen-Ching
    Huang, Yu-Tung
    Hsieh, I-Chang
    Chang, Shang-Hung
    [J]. MEDICINE, 2022, 101 (36) : E30426
  • [10] Is The Diagnosis ST-Segment Elevation or Non-ST-Segment Elevation Myocardial Infarction?
    Tsutsumi, Katsuhiko
    Tsukahara, Kengo
    [J]. CIRCULATION, 2018, 138 (23) : 2715 - 2717